Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

853 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Genome-wide association study identifies CDH13 as a susceptibility gene for rhododendrol-induced leukoderma.
Okamura K, Abe Y, Naka I, Ohashi J, Yagami A, Matsunaga K, Kobayashi Y, Fukai K, Tanemura A, Katayama I, Masui Y, Ito A, Yamashita T, Nagai H, Nishigori C, Oiso N, Aoyama Y, Araki Y, Saito T, Hayashi M, Hozumi Y, Suzuki T. Okamura K, et al. Among authors: katayama i. Pigment Cell Melanoma Res. 2020 Nov;33(6):826-833. doi: 10.1111/pcmr.12904. Epub 2020 Jun 29. Pigment Cell Melanoma Res. 2020. PMID: 32558222
Autoantibodies detected in patients with vitiligo vulgaris but not in those with rhododendrol-induced leukoderma.
Arase N, Tanemura A, Jin H, Nishioka M, Aoyama Y, Oiso N, Matsunaga K, Suzuki T, Nishigori C, Kawamura T, Shimizu T, Ito A, Fukai K, Abe Y, Yang L, Tsuruta D, Takeoka K, Iwatani Y, Hidaka Y, Nishida M, Yamauchi-Takihara K, Arase H, Fujimoto M, Katayama I. Arase N, et al. Among authors: katayama i. J Dermatol Sci. 2019 Aug;95(2):80-83. doi: 10.1016/j.jdermsci.2019.06.009. Epub 2019 Jul 2. J Dermatol Sci. 2019. PMID: 31399283 No abstract available.
Rhododendrol-induced leukoderma update I: Clinical findings and treatment.
Matsunaga K, Suzuki K, Ito A, Tanemura A, Abe Y, Suzuki T, Yoshikawa M, Sumikawa Y, Yagami A, Masui Y, Inoue S, Ito S, Katayama I. Matsunaga K, et al. Among authors: katayama i. J Dermatol. 2021 Jul;48(7):961-968. doi: 10.1111/1346-8138.15835. Epub 2021 Mar 8. J Dermatol. 2021. PMID: 33686651 Free PMC article. Review.
Rhododendrol-induced leukoderma update II: Pathophysiology, mechanisms, risk evaluation, and possible mechanism-based treatments in comparison with vitiligo.
Inoue S, Katayama I, Suzuki T, Tanemura A, Ito S, Abe Y, Sumikawa Y, Yoshikawa M, Suzuki K, Yagami A, Masui Y, Ito A, Matsunaga K. Inoue S, et al. Among authors: katayama i. J Dermatol. 2021 Jul;48(7):969-978. doi: 10.1111/1346-8138.15878. Epub 2021 May 5. J Dermatol. 2021. PMID: 33951216 Free PMC article. Review.
Guidelines for the diagnosis and treatment of vitiligo in Japan.
Oiso N, Suzuki T, Wataya-Kaneda M, Tanemura A, Tanioka M, Fujimoto T, Fukai K, Kawakami T, Tsukamoto K, Yamaguchi Y, Sano S, Mitsuhashi Y, Nishigori C, Morita A, Nakagawa H, Mizoguchi M, Katayama I. Oiso N, et al. Among authors: katayama i. J Dermatol. 2013 May;40(5):344-54. doi: 10.1111/1346-8138.12099. Epub 2013 Feb 27. J Dermatol. 2013. PMID: 23441960
853 results